Literature DB >> 12551978

Murine gammaherpesvirus 68 lacking thymidine kinase shows severe attenuation of lytic cycle replication in vivo but still establishes latency.

Heather M Coleman1, Brigitte de Lima, Victoria Morton, Philip G Stevenson.   

Abstract

The lytic cycle functions of gammaherpesviruses have received relatively little attention to date, at least in part due to the lack of a convenient experimental model. The murine gammaherpesvirus 68 (MHV-68) now provides such a model and allows the roles of individual lytic cycle gammaherpesvirus proteins to be evaluated in vivo. We have used MHV-68 to determine the contribution of a gammaherpesvirus thymidine kinase (TK) to viral lytic replication and latency establishment. MHV-68 mutants with a disrupted TK gene grew normally in vitro but showed a severe attenuation of replication in the lungs after intranasal inoculation, with lytic titers at least 1,000-fold lower than those of wild-type and revertant viruses. Nevertheless, the establishment of latency by the TK-deficient mutants, while delayed, was not prevented by their lytic replication deficit. The viral TK clearly plays a crucial role in the capacity of MHV-68 to replicate efficiently in its natural host but does not seem to be essential to establish a persistent infection. The potential of TK-deficient mutants as gammaherpesvirus vaccines is discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12551978      PMCID: PMC141081          DOI: 10.1128/jvi.77.4.2410-2417.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  Human herpesvirus 8 open reading frame 21 is a thymidine and thymidylate kinase of narrow substrate specificity that efficiently phosphorylates zidovudine but not ganciclovir.

Authors:  E A Gustafson; R F Schinazi; J D Fingeroth
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  2'-Deoxy-5-ethyl-beta-4'-thiouridine inhibits replication of murine gammaherpesvirus and delays the onset of virus latency.

Authors:  A Barnes; H Dyson; N P Sunil-Chandra; P Collins; A A Nash
Journal:  Antivir Chem Chemother       Date:  1999-11

3.  Macrophages are the major reservoir of latent murine gammaherpesvirus 68 in peritoneal cells.

Authors:  K E Weck; S S Kim; I V Virgin HW; S H Speck
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

4.  Analysis of the virus-specific and nonspecific B cell response to a persistent B-lymphotropic gammaherpesvirus.

Authors:  M Y Sangster; D J Topham; S D'Costa; R D Cardin; T N Marion; L K Myers; P C Doherty
Journal:  J Immunol       Date:  2000-02-15       Impact factor: 5.422

5.  EBV persistence in memory B cells in vivo.

Authors:  G J Babcock; L L Decker; M Volk; D A Thorley-Lawson
Journal:  Immunity       Date:  1998-09       Impact factor: 31.745

6.  Latent murine gamma-herpesvirus infection is established in activated B cells, dendritic cells, and macrophages.

Authors:  E Flaño; S M Husain; J T Sample; D L Woodland; M A Blackman
Journal:  J Immunol       Date:  2000-07-15       Impact factor: 5.422

7.  A gamma-herpesvirus sneaks through a CD8(+) T cell response primed to a lytic-phase epitope.

Authors:  P G Stevenson; G T Belz; M R Castrucci; J D Altman; P C Doherty
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

8.  T-cell vaccination alters the course of murine herpesvirus 68 infection and the establishment of viral latency in mice.

Authors:  L Liu; E J Usherwood; M A Blackman; D L Woodland
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

9.  In vitro and in vivo inhibition of murine gamma herpesvirus 68 replication by selected antiviral agents.

Authors:  J Neyts; E De Clercq
Journal:  Antimicrob Agents Chemother       Date:  1998-01       Impact factor: 5.191

10.  Murine gamma-herpesvirus 68 glycoprotein 150 protects against virus-induced mononucleosis: a model system for gamma-herpesvirus vaccination.

Authors:  J P Stewart; N Micali; E J Usherwood; L Bonina; A A Nash
Journal:  Vaccine       Date:  1999-01       Impact factor: 3.641

View more
  36 in total

1.  Dendritic cells loaded with tumor B cells elicit broad immunity against murine gammaherpesvirus 68 but fail to prevent long-term latency.

Authors:  Janet Weslow-Schmidt; Fang Ye; Stephanie S Cush; Kathleen A Stuller; Marcia A Blackman; Emilio Flaño
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

2.  Identification of viral genes essential for replication of murine gamma-herpesvirus 68 using signature-tagged mutagenesis.

Authors:  Moon Jung Song; Seungmin Hwang; Wendy H Wong; Ting-Ting Wu; Sangmi Lee; Hsiang-I Liao; Ren Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-28       Impact factor: 11.205

3.  Functional divergence of Kaposi's sarcoma-associated herpesvirus and related gamma-2 herpesvirus thymidine kinases: novel cytoplasmic phosphoproteins that alter cellular morphology and disrupt adhesion.

Authors:  Michael B Gill; Jo-Ellen Murphy; Joyce D Fingeroth
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

4.  Early establishment of gamma-herpesvirus latency: implications for immune control.

Authors:  Emilio Flaño; Qingmei Jia; John Moore; David L Woodland; Ren Sun; Marcia A Blackman
Journal:  J Immunol       Date:  2005-04-15       Impact factor: 5.422

5.  Evidence for CDK-dependent and CDK-independent functions of the murine gammaherpesvirus 68 v-cyclin.

Authors:  Jason W Upton; Samuel H Speck
Journal:  J Virol       Date:  2006-09-27       Impact factor: 5.103

6.  Epstein-Barr virus thymidine kinase is a centrosomal resident precisely localized to the periphery of centrioles.

Authors:  Michael B Gill; Jeffery L Kutok; Joyce D Fingeroth
Journal:  J Virol       Date:  2007-04-11       Impact factor: 5.103

7.  Murine gammaherpesvirus-68 glycoprotein B presents a difficult neutralization target to monoclonal antibodies derived from infected mice.

Authors:  Laurent Gillet; Michael B Gill; Susanna Colaco; Christopher M Smith; Philip G Stevenson
Journal:  J Gen Virol       Date:  2006-12       Impact factor: 3.891

8.  A Thymidine Kinase recombinant protein-based ELISA for detecting antibodies to Duck Plague Virus.

Authors:  Yongping Wen; Anchun Cheng; Mingshu Wang; Han Ge; Chanjuan Shen; Sitong Liu; Jun Xiang; Renyong Jia; Dekang Zhu; Xiaoyue Chen; Bei Lian; Hua Chang; Yi Zhou
Journal:  Virol J       Date:  2010-04-23       Impact factor: 4.099

9.  Murid herpesvirus-4 lacking thymidine kinase reveals route-dependent requirements for host colonization.

Authors:  Michael B Gill; Debbie E Wright; Christopher M Smith; Janet S May; Philip G Stevenson
Journal:  J Gen Virol       Date:  2009-03-04       Impact factor: 3.891

10.  In vivo imaging of murid herpesvirus-4 infection.

Authors:  Ricardo Milho; Christopher M Smith; Sofia Marques; Marta Alenquer; Janet S May; Laurent Gillet; Miguel Gaspar; Stacey Efstathiou; J Pedro Simas; Philip G Stevenson
Journal:  J Gen Virol       Date:  2009-01       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.